Literature DB >> 1595150

Prevalence of mitral valve insufficiency in cavalier King Charles spaniels.

R Malik1, G B Hunt, G S Allan.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1595150     DOI: 10.1136/vr.130.14.302

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


× No keyword cloud information.
  6 in total

1.  Evaluation of the Swedish breeding program for cavalier King Charles spaniels.

Authors:  Tobias Lundin; Clarence Kvart
Journal:  Acta Vet Scand       Date:  2010-09-23       Impact factor: 1.695

2.  Antioxidative enzyme activity and total antioxidant capacity in serum of dogs with degenerative mitral valve disease.

Authors:  Marcin Michałek; Aleksandra Tabiś; Alicja Cepiel; Agnieszka Noszczyk-Nowak
Journal:  Can J Vet Res       Date:  2020-01       Impact factor: 1.310

3.  Prevalence of disorders recorded in Cavalier King Charles Spaniels attending primary-care veterinary practices in England.

Authors:  Jennifer F Summers; Dan G O'Neill; David B Church; Peter C Thomson; Paul D McGreevy; David C Brodbelt
Journal:  Canine Genet Epidemiol       Date:  2015-04-18

4.  Degenerative Valvular Disease in the Cavalier King Charles Spaniel: Results of the UK Breed Scheme 1991-2010.

Authors:  S Swift; A Baldin; P Cripps
Journal:  J Vet Intern Med       Date:  2017-01-05       Impact factor: 3.333

5.  Mitral Regurgitation in Dachshund Dogs without Heart Murmurs.

Authors:  Magdalena Garncarz; Marta Parzeniecka-Jaworska; Magdalena Hulanicka; Michał Jank; Olga Szaluś-Jordanow; Anna Kurek
Journal:  J Vet Res       Date:  2017-09-19       Impact factor: 1.744

6.  Comparison of the mitral valve morphologies of Cavalier King Charles Spaniels and dogs of other breeds using 3D transthoracic echocardiography.

Authors:  Giulio Menciotti; Michele Borgarelli; Michael Aherne; Paula Camacho; Jens Häggström; Ingrid Ljungvall; Sunshine M Lahmers; Jonathan A Abbott
Journal:  J Vet Intern Med       Date:  2018-09-20       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.